Works matching IS 13518216 AND DT 2024 AND VI 30
Results: 216
Assessment of joint health in females with haemophilia: The carriers ultrasound project (CUP) study.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1422, doi. 10.1111/hae.15128
- By:
- Publication type:
- Article
Thirty Years of the Journal Haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1255, doi. 10.1111/hae.15127
- By:
- Publication type:
- Article
One day at a time: Life with Glanzmann thrombasthenia – Qualitative results from the GT 360 study.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1373, doi. 10.1111/hae.15126
- By:
- Publication type:
- Article
A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: The coreVWD initiative.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1357, doi. 10.1111/hae.15122
- By:
- Publication type:
- Article
The haemophilia joint health score for the assessment of joint health in patients with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1265, doi. 10.1111/hae.15116
- By:
- Publication type:
- Article
Assessment of haemophilic joints in a low‐resourced area using clinical tools: The effect of different types of prophylaxis.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1414, doi. 10.1111/hae.15115
- By:
- Publication type:
- Article
Performance of instrumental activities of daily living in patients with haemophilic arthropathy. A cross‐sectional cohort study.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1406, doi. 10.1111/hae.15114
- By:
- Publication type:
- Article
Evaluating the impact of the self‐BAT screening tool on patient outcomes: Results of the let's talk period project.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1400, doi. 10.1111/hae.15113
- By:
- Publication type:
- Article
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1272, doi. 10.1111/hae.15108
- By:
- Publication type:
- Article
Haemophilia testing of young girls in Canada: Describing the current recommendations for factor level and genetic testing and the experiences of Canadian parents.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1393, doi. 10.1111/hae.15107
- By:
- Publication type:
- Article
NXT007 does not interfere with the anticoagulant effects on tissue factor pathway inhibitor.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1435, doi. 10.1111/hae.15106
- By:
- Publication type:
- Article
Evaluating the benefits of emicizumab prophylaxis for haemophilia A with inhibitors: A cost‐effectiveness and budget impact analysis in Thailand's upper‐middle income setting.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1288, doi. 10.1111/hae.15105
- By:
- Publication type:
- Article
Voices of patients with hemophilia: Life‐changing gene therapy.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1444, doi. 10.1111/hae.15104
- By:
- Publication type:
- Article
Patient‐reported data on the severity of Von Willebrand disease.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1348, doi. 10.1111/hae.15103
- By:
- Publication type:
- Article
Women and girls' participation in haemophilia clinical trials.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1440, doi. 10.1111/hae.15101
- By:
- Publication type:
- Article
Development of the World Federation of Hemophilia Shared Decision‐Making Tool.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1298, doi. 10.1111/hae.15100
- By:
- Publication type:
- Article
Low vitamin C status and hypermobility‐related disorders in patients with bleeding disorder of unknown cause.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1366, doi. 10.1111/hae.15099
- By:
- Publication type:
- Article
Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1341, doi. 10.1111/hae.15098
- By:
- Publication type:
- Article
Pathogenesis of osteoarthritis, rheumatoid arthritis, and hemophilic arthropathy: The role of angiogenesis.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1256, doi. 10.1111/hae.15097
- By:
- Publication type:
- Article
Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi‐criteria decision analysis.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1281, doi. 10.1111/hae.15096
- By:
- Publication type:
- Article
We need better health‐related quality‐of‐life data for children with haemophilia in lower‐income countries.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1429, doi. 10.1111/hae.15095
- By:
- Publication type:
- Article
Real‐world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi‐institutional case series.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1321, doi. 10.1111/hae.15094
- By:
- Publication type:
- Article
Democratisation of physiotherapy for people with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1432, doi. 10.1111/hae.15092
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1251, doi. 10.1111/hae.14733
- Publication type:
- Article
Determination of body composition by dual x‐ray absorptiometry in persons with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1332, doi. 10.1111/hae.15091
- By:
- Publication type:
- Article
Differences and similarities in patient‐reported outcomes among men and women with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1383, doi. 10.1111/hae.15090
- By:
- Publication type:
- Article
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1138, doi. 10.1111/hae.15071
- By:
- Publication type:
- Article
Development of the coreHEM mental health patient‐reported outcome measure – A novel mental health outlook measure for people with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 6, p. 1309, doi. 10.1111/hae.15085
- By:
- Publication type:
- Article
Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1203, doi. 10.1111/hae.15089
- By:
- Publication type:
- Article
Real world management of individuals with severe FXI deficiency and its impact on clinical outcomes: Experience from a haemophilia treatment centre.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1164, doi. 10.1111/hae.15075
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1105, doi. 10.1111/hae.15093
- Publication type:
- Article
Driving improvement of diagnosis and awareness of heavy menstrual bleeding in women among physicians.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1185, doi. 10.1111/hae.15088
- By:
- Publication type:
- Article
Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1170, doi. 10.1111/hae.15087
- By:
- Publication type:
- Article
Acute neuromuscular and perceptual responses to blood flow restriction exercise in adults with severe haemophilia: A pilot study.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1193, doi. 10.1111/hae.15084
- By:
- Publication type:
- Article
Sexual functioning in men with haemophilia: Data from the haemophilia in the Netherlands‐6 study.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1243, doi. 10.1111/hae.15083
- By:
- Publication type:
- Article
Transitioning patients with severe haemophilia A from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: Real‐world clinical experience.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1247, doi. 10.1111/hae.15086
- By:
- Publication type:
- Article
Bioclinical features of haemophilia patients in Benin in 2023: Towards better care.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1210, doi. 10.1111/hae.15082
- By:
- Publication type:
- Article
Diagnosis and management of factor XI alloinhibitors in patients with congenital factor XI deficiency—A large single‐centre experience.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1155, doi. 10.1111/hae.15081
- By:
- Publication type:
- Article
Application of the PECARN head trauma rule to patients with haemophilia in the paediatric emergency department: A 15‐year retrospective study.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1238, doi. 10.1111/hae.15080
- By:
- Publication type:
- Article
Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1148, doi. 10.1111/hae.15079
- By:
- Publication type:
- Article
Emicizumab plasma levels after accelerated saturation in acquired haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1227, doi. 10.1111/hae.15069
- By:
- Publication type:
- Article
A case of bruising and joint hypermobility: The need to consider genetic testing for platelet disorders.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1225, doi. 10.1111/hae.15066
- By:
- Publication type:
- Article
Review of interventions and effectiveness for heavy menstrual bleeding in women with moderate and severe von Willebrand disease.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1177, doi. 10.1111/hae.15078
- By:
- Publication type:
- Article
Multiyear, real‐world, retrospective cohort study using a patient‐centric approach to evaluate the burden of haemophilia B in the United States.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1234, doi. 10.1111/hae.15077
- By:
- Publication type:
- Article
Recombinant FVIII replacement products for haemophilia A: An updated valuation by indirect comparison measuring area under the curve.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1230, doi. 10.1111/hae.15076
- By:
- Publication type:
- Article
A clinical practice guideline for primary care physiotherapy in patients with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1115, doi. 10.1111/hae.15065
- By:
- Publication type:
- Article
A qualitative study on the perioperative experiences and demands of haemophilic arthropathy patients undergoing total joint replacement.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 1050, doi. 10.1111/hae.15073
- By:
- Publication type:
- Article
Low bleeding rates after intramuscular Covid‐19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1217, doi. 10.1111/hae.15063
- By:
- Publication type:
- Article
Acquired haemophilia A in Finland: A nationwide study of incidence, treatment and outcomes.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1130, doi. 10.1111/hae.15037
- By:
- Publication type:
- Article
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1109, doi. 10.1111/hae.15031
- By:
- Publication type:
- Article